Current Flu Vaccine News and Events

Current Flu Vaccine News and Events, Flu Vaccine News Articles.
Sort By: Most Relevant | Most Viewed
Page 1 of 25 | 1000 Results
University of Minnesota researchers develop two new rapid COVID-19 diagnostic tests
University of Minnesota Medical School researchers have developed two new rapid diagnostic tests for COVID-19 - one to detect COVID-19 variants and one to help differentiate with other illnesses that have COVID-19-like symptoms. (2021-02-23)

Biological therapy has proved a suitable alternative to antibiotics
Tel Aviv University researchers have developed a biological substitute for the treatment of tuberculosis, which in the future could serve as an alternative for the traditional ''chemical'' antibiotic therapy. Dr. Freund: ''Advances in molecular medicine enable us to develop new tools to rout microbes, which can also solve the problem of drug-resistant germs''. This groundbreaking study has been published in the prestigious scientific journal Nature Communications. (2021-02-22)

Researchers learn that pregnant women pass along protective COVID antibodies to their babies
Antibodies that guard against COVID-19 can transfer from mothers to babies while in the womb, according to a new study from Weill Cornell Medicine and NewYork-Presbyterian researchers published in the American Journal of Obstetrics and Gynecology. (2021-02-22)

CovMT: Tracking virus mutations across the world
An interactive platform helps users visualize where SARS-CoV-2 mutations start, how wide they spread and how infectious they are. (2021-02-21)

New study highlights lack of diversity and inclusion in vaccine clinical trials
A team of scientific experts from across the U.S. and Puerto Rico are advocating for increased diversity in vaccine trials after publishing a new report that highlights a decade's worth of disparities. (2021-02-19)

Including racial/ethnic minorities, females, older adults in vaccine trials
Using data from completed interventional vaccine trials from 2011 to 2020, researchers examined whether racial/ethnic minority groups, females and older adults were underrepresented in U.S.-based vaccine clinical trials. (2021-02-19)

COVID-19 may have caused the loss of more than 20.5 million years of life worldwide
A study by a group researchers from several international universities and research centres, including lecturers from the UPF Department of Economics and Business, has estimated the premature mortality impact of covid-19. It has done so by calculating years of life lost (YLL) due to covid-19 compared to YLL for other common illnesses, such as the flu or cardiovascular diseases. (2021-02-19)

New review compiles immunogenicity data on leading SARS-CoV-2 vaccine candidates
In a new Review, P.J. Klasse and colleagues present an extensive overview of the immunogenicity profiles of several leading SARS-CoV-2 vaccine candidates, including several developed under the auspices of (2021-02-19)

The Lancet: 3-month interval between first and second dose of Oxford COVID-19 vaccine results in higher vaccine efficacy than 6-week interval
* Exploratory analyses including 17,178 participants find that higher vaccine efficacy is obtained with a longer interval between the first and second standard dose (81% for 3-month interval vs 55% for up to 6-week interval). In addition, a single dose of vaccine is highly efficacious in the first 3 months (76% efficacy from 22 days after vaccination onwards). (2021-02-19)

As insurers end grace period for COVID-19 hospital costs, study estimates potential bills
Hospital care for COVID-19 has been free to most patients, but insurance companies may be ending that. A study of flu-related hospital bills suggests a coronavirus hospital stay could now cost patients $1,000 out of their own pocket, on average. (2021-02-18)

'Classic triad' of symptoms misses positive COVID-19 cases, study finds
Extending the symptoms that trigger a PCR test for COVID-19 could help detect around a third more cases of the disease. (2021-02-18)

Older adults and antibiotics: Study shows healthy attitudes but unhealthy practices
While most adults over 50 understand that overuse of antibiotics is a problem, and say they're cautious about taking the drugs, a sizable minority have used antibiotics for something other than their original purpose, and appear to think the drugs could help treat colds, which are caused by viruses not bacteria. (2021-02-18)

The Lancet Healthy Longevity: Study finds racial and ethnic disparities in flu vaccine uptake among people aged 65 and older in the USA
A new study published today in The Lancet Healthy Longevity journal has found significant racial and ethnic disparities in uptake of the seasonal influenza vaccine among people aged 65 years and over in the USA. (2021-02-18)

Asthma may heighten flu risk and cause dangerous mutations
A subtype of asthma in adults may cause higher susceptibility to influenza and could result in dangerous flu mutations. University of Queensland-led animal studies have found that paucigranulocytic asthma (PGA) - a non-allergic form of the condition - allows the flu virus to flourish in greater numbers in sufferers. (2021-02-16)

It's morally wrong for rich nations to hoard COVID-19 vaccine
Rich nations should not engage in ''vaccine nationalism'' and keep the COVID-19 vaccine to themselves when poorer nations need them, according to Nicole Hassoun, professor of philosophy at Binghamton University, State University of New York. Hassoun's paper, ''Against Vaccine Nationalism,'' was published in the Journal of Medical Ethics. (2021-02-16)

COVID-19 infection rates high in pregnant women
The study also showed that the number of COVID-19 infections in pregnant patients from nearly all communities of color in Washington was high. There was a twofold to fourfold higher prevalence of pregnant patients with COVID-19 infections from communities of color than expected based on the race-ethnicity distribution of pregnant women in Washington in 2018. (2021-02-16)

NIH experts discuss SARS-CoV-2 viral variants
The rise of significant variants of SARS-CoV-2 has attracted the attention of health and science experts worldwide. In an editorial published in JAMA, experts from the National Institute of Allergy and Infectious Diseases outline how these variants have arisen, concerns about whether vaccines currently authorized for use will continue to protect against new variants, and the need for a global approach to fighting SARS-CoV-2 as it spreads and acquires additional mutations. (2021-02-12)

ACC urges COVID-19 vaccine prioritization for highest risk heart disease patients
COVID-19 vaccine prioritization should prioritize those with advanced cardiovascular (CVD) disease over well-managed CVD disease, according to an American College of Cardiology (ACC) health policy statement published in the Journal of the American College of Cardiology (JACC). (2021-02-12)

The Lancet: COVID-19 vaccination potential will not be achieved without increased production, affordable pricing, global availability, and successful rollout
Having new COVID-19 vaccines will mean little if people around the world are unable to get vaccinated in a timely manner. Vaccines have to be affordable and available to all countries, and governments must have the administrative and political capacities to deliver them locally to ensure an effective global immunisation strategy against COVID-19, say the authors of a Health Policy piece published in The Lancet. (2021-02-12)

New ACIP Adult Immunization Schedule recommends changes to several vaccines, includes interim recomm
The Advisory Committee on Immunization Practices (ACIP) has released its 2021 Recommended Adult Immunization Schedule that includes changes to several vaccines including influenza, hepatitis A, human papillomavirus (HPV); and the measles, mumps and rubella (MMR) vaccine. The schedule also includes interim recommendations for COVID-19 vaccination. The complete schedule, including changes in the vaccine notes section, is being simultaneously published in Annals of Internal Medicine and on the Centers for Disease Control and Prevention (CDC) web site. (2021-02-11)

One dose of COVID-19 vaccine provokes strong immune response in those previously infected
Researchers report preliminary evidence that people previously infected with COVID-19 responded very strongly to one dose of the Pfizer vaccine, regardless of when they were infected and whether or not they had detectable antibodies against COVID-19 prior to receiving the vaccine. The response was so effective that it opens the debate as to whether one dose of the vaccine may suffice. The research also provided evidence that immune response was similar across multi-ethnic groups. (2021-02-11)

Study predicts UK COVID-19 vaccination program will very quickly reduce deaths but more slowly bring down hospital and ICU admissions
A new modelling study published in Anaesthesia (a journal of the Association of Anaesthetists) shows that the UK's coronavirus vaccination program is already reducing daily deaths. However, reductions of hospital and intensive care (ICU) admissions will likely take several weeks longer, with large reductions seen by the end of March and continuing into April. (2021-02-11)

Study finds U.S. first responders have mixed feelings about COVID-19 vaccine
Firefighters and emergency medical services workers are at high risk of exposure to COVID-19 while on the job and pose an additional risk of transmitting the virus to others. Although vaccines are a promising public health tool for reducing COVID-19 transmission, little has been known about the perceptions of the COVID-19 vaccine among first responders. (2021-02-10)

Caution: 1918 influenza provides warning for potential future pandemic reemergence
New research from Michigan State University used health data from the initial 1918 influenza spike to provide insights to what ''pandemic reemergence'' may look like for our future. (2021-02-10)

Lessons from the flu season
Australian researchers have come up with two key recommendations from studies of the annual influenza season - one highlighting the benefits of antivirals in reducing repeat hospitalisation, and the other to watch for underlying cardiovascular disease. While the world focuses on the rising COVID-19 death toll, seasonal influenza continues to cause significant mortality and poses a significant economic burden every year. (2021-02-10)

Experts' top COVID mitigation action: Nat'l stay at home order with financial compensation
A report summary released today by a team at Lehigh University led by Thomas McAndrew, a computational scientist and assistant professor in Lehigh's College of Health, shares the consensus results of experts in the modeling of infectious disease when asked to rank the top 5 most effective interventions to mitigate the spread and impact of COVID-19 in the US. (2021-02-10)

Vaccine confidence grows under new administration, latest CUNY SPH Survey reveals
Under the Biden Administration, New Yorkers' acceptance of the Covid-19 vaccine has increased significantly. In September, 55% of residents reported they would take the vaccine when it became available and this January, 64% reported they would take it. (2021-02-09)

Scientists urge for investment now in highly potent vaccines to prevent the next pandemic
In an article that appears in the journal Nature, Dennis Burton, PhD, and Eric Topol, MD, of Scripps Research call for governments to provide significant funding support for rational vaccine design based on broadly neutralizing antibodies. Such antibodies provide broad-spectrum potency against viruses, a valuable characteristic that opens the door to vaccines that could provide immunity against the many variants that might evolve from a fast-mutating virus. They could also be used as drugs to prevent and treat infections. (2021-02-09)

Arizona economic burden of valley fever totals $736 million
Expenses for the fungal disease endemic to the Southwest can skyrocket for people whose diagnosis is delayed, leading to more serious infection or death. (2021-02-09)

Survey: Most Americans say they'll continue health precautions after COVID-19
A new national survey of more than 2,000 Americans by The Ohio State University Wexner Medical Center finds most plan to continue many of the pandemic precautions in the name of public health, even when the pandemic is over. (2021-02-08)

History of vaccines offers lessons on COVID-19 for pregnant women
DALLAS - Feb. 8, 2021 - Pregnant women, who are at increased risk of preterm birth or pregnancy loss if they develop a severe case of COVID-19, need the best possible guidance on whether they should receive a COVID-19 vaccine, according to an article by two UT Southwestern obstetricians published today in JAMA. That guidance can take lessons from what is already known about other vaccines given during pregnancy. (2021-02-08)

1918 pandemic second wave had fatal consequences
In the event of a pandemic, delayed reactions and a decentralized approach by the authorities at the start of a follow-up wave can lead to longer-lasting, more severe and more fatal consequences, researchers from the universities of Zurich and Toronto have found. The interdisciplinary team compared the Spanish flu of 1918 and 1919 in the Canton of Bern with the coronavirus pandemic of 2020. (2021-02-08)

Higher excess COVID-19 death risk in middle-aged people with type 2 diabetes
A largescale analysis led by the University of Exeter and funded by Diabetes UK, has found a disproportionately higher COVID-19 death risk in middle-aged people with type 2 diabetes, raising questions over vaccination strategies across Europe. (2021-02-08)

New AI tool can thwart coronavirus mutations
USC computer scientists used AI to create a new tool that rapidly identifies potential solutions to coronavirus mutations and screens vaccines much faster to give humans an advantage over the contagion. (2021-02-05)

The Lancet Public Health: Survey taken after France's first COVID-19 wave indicates almost one-third of working-age people could reject a vaccine
Nearly one in three working-age adults in France (29%) surveyed in July 2020 - when lockdown restrictions had been eased - were outright opposed to being vaccinated against the virus, according to new research published in The Lancet Public Health journal. (2021-02-05)

City, University of London academic tracks COVID-19 dark web marketplaces
New research carried out by Dr Andrea Baronchelli and his colleagues into the dark web marketplace (DWM) trade in products related to COVID-19, has revealed the need for the continuous monitoring of dark web marketplaces (DWMs), especially in light of the current shortage and availability of coronavirus vaccines. (2021-02-04)

Study shows flu vaccine lessens COVID-19 symptoms in children
Researchers from the University of Missouri School of Medicine have discovered that children who receive a seasonal flu shot are less likely to suffer symptoms from a COVID-19 infection. The finding comes from a review of more than 900 children diagnosed with COVID-19 in 2020. (2021-02-04)

COVID-19 vaccine from new vaccine platform effective in mice
It is necessary to develop additional COVID-19 vaccines, as different vaccine approaches have their advantages and disadvantages and may work synergistically. Researchers at Karolinska Institutet in Sweden now report that they have developed a prototype vaccine against SARS-CoV-2 using a DNA vaccine platform that is inexpensive, stable, easy to produce, and shows a good safety profile. A study published in Scientific Reports shows that the vaccine induces potent immune responses in mice. (2021-02-04)

Emory MVA COVID-19 vaccine safe and effective in animal models
Yerkes NPRC/Emory University researchers have developed a COVID-19 vaccine that has proven safe and effective in mice and monkeys. The Emory MVA COVID-19 vaccine uses modified vaccinia Ankara (MVA) to induce strong neutralizing antibodies and killer CD8 T cells. Researchers say the vaccine is easily adaptable to address variants, can be used in combination with existing vaccines to improve their ability to combat variants and may be equally effective with a single dose. (2021-02-04)

City, University of London academic tracks COVID-19 dark web marketplace before vaccine
Dr Andrea Baronchelli, and colleagues have carried out insightful research into the dark web marketplace (DWM) trade in products related to COVID-19; they have revealed the need for the continuous monitoring of dark web marketplaces (DWMs) especially in light of the current shortage and availability of coronavirus vaccines. (2021-02-04)

Page 1 of 25 | 1000 Results
   First   Previous   Next      Last   
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.